Eli Lilly, Johnson & Johnson, and AbbVie led a healthcare sector surge, hitting new annual peaks amid broader market gains.
Healthcare stocks outperformed on Wall Street Friday, with Eli Lilly (LLY), Johnson & Johnson (JNJ), and AbbVie (ABBV) climbing to 52-week highs. The sector, a component of the S&P 500, rebounded despite year-to-date underperformance relative to other industries.
The gains followed a period of relative weakness for healthcare equities, which had lagged broader market indices. The rally marked a sharp reversal, with the three companies leading the sector’s advance.
No immediate market reaction data was provided, but the sector’s strength contrasted with its earlier sluggish performance in 2024.